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ABSTRACT
The present study compares dosimetric parameters between volumetric-modulated arc therapy (VMAT) and
3D conformal radiation therapy (3D-CRT) in lung tumors adjacent to the chest wall treated with stereotactic
body radiation therapy (SBRT). The study focused on the radiation dose to the chest wall of 16 patients who
had developed radiation-induced rib fractures (RIRF) after SBRT using 3D-CRT. The targets in all patients
were partially overlapping with the fractured ribs, and the median overlapping rib–PTV distance was 0.4 cm.
Stereotactic body radiation therapy was re-planned for all patients. The prescribed dose was 48 Gy in four
fractions to cover at least 95% of the planning target volume (PTV). Evaluated dosimetric factors included
D98% and the conformation number (CN) of the PTV, the D2cm3, V40 and V30 of the fractured ribs, the V30 of
the chest wall, and the Dmean, V20 and V5 of the lung. A comparison of 3D-CRT with the VMAT plan for PTV
revealed that CN was significantly improved in the VMAT plan, whereas D98% did not significantly differ between the
two plans. Regarding organs at risk (OARs), the D2cm3, V40 and V30 of fractured ribs, the V30 of the chest wall, and
the Dmean, V20 and V5 of the lung, were significantly decreased in the VMAT plan. We concluded that the dose to
OARs such as ribs and chest wall could be reduced with improved target conformity using VMAT instead of 3D-
CRT for SBRT to treat peripheral lung tumors.
Keywords: stereotactic body radiation therapy (SBRT); three-dimensional conformal radiation therapy (3D-
CRT); volumetric-modulated arc therapy (VMAT); non–small cell lung cancer (NSCLC); chest wall pain;
radiation-induced rib fracture (RIRF)
INTRODUCTION
Stereotactic body radiation therapy (SBRT) allows escalation of the
fractional dose to the target while minimizing the radiation dose to
normal tissue, resulting in excellent local control and survival rates,
with limited toxicity in patients with medically inoperable early-
stage non–small cell lung cancer (NSCLC) [1].
Three-dimensional conformal radiation therapy (3D-CRT),
dynamic conformal arc therapy (DCAT) and volumetric-modulated
© The Author(s) 2018. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.
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arc therapy (VMAT) are three main irradiation techniques in lung
SBRT [2, 3]. The 3D-CRT, which is the conventional irradiation
technique for SBRT, uses multiple static fields (from 7 to 11 fields
in most cases) including coplanar and noncoplanar beams. Though
this technique has a highly conformal dose distribution by concen-
trating the dose to the target from all directions, a steep dose
gradient between the target and organs at risk (OARs) adjacent to
the target is difficult to achieve. For example, the chest wall is irra-
diated with a high dose during treatment for peripheral lung tumors
adjacent to chest wall. Therefore, adverse events such as radiation-
induced rib fracture (RIRF) and chest wall pain occur in many cases
after SBRT [4–8]. Several studies have reported that the incidence
of RIRF after SBRT for lung tumors was 23–37% [9–12]. Clinical
factors such as target location [9], female sex [10, 13] and rib–
tumor distance [12–14] are known to increase the risk of RIRF
and chest wall pain after SBRT for lung tumors. Regarding dosi-
metric factors, a high-dose-irradiated volume of the chest wall is
thought to contribute to the increased the incidence of such adverse
events [7, 8, 15]. VMAT, a novel irradiation technique for SBRT,
should reduce the dose to the chest wall through inverse planning.
Ding et al. compared dosimetric parameters of OARs in lung cancer
adjacent to the chest wall (average 2 cm) between a static field plan
and VMAT. They found that the VMAT plan significantly decreased
the V30 for the rib and chest wall, and the V20 for the lung, except in
one patient [16]. These findings suggest that the VMAT plan
reduces the OARs dose compared with the static field plan.
However, that study did not take differences in the target dose into
account when comparing the two plans. Furthermore, whether or
not the dose to the chest wall can decrease with VMAT is unknown
in cases where the target is overlapping with the fractured ribs in
patients who develop RIRF. If VMAT could reduce the dose to the
chest wall in these patients, then the risk of such adverse events after
SBRT should be decreased.
The present study aimed to determine whether or not the dose
to the chest wall could be decreased by VMAT in patients with
RIRF. The study also compared the dose to the target and to the
OARs adjacent to the target between the two plans.
MATERIALS AND METHODS
Patient characteristics
The patients who developed RIRF after SBRT at Kyushu University
between April 2003 and May 2007 were retrospectively reviewed. The
analysis included 28 ribs in 16 patients in this study. The inclusion cri-
teria for this study were as follows: (i) early-stage primary or meta-
static lung cancer; (ii) prescribed 48 Gy in four fractions to the
isocenter; (iii) developed RIRF after SBRT with 3D-CRT and (iv)
planning target volume (PTV) partially overlapping with the fractured
rib, and <0.6 cm overlap between the rib and the PTV. Patients with
an overlapping rib–PTV distance >0.6 cm were excluded from the
study due to the difficulty in reducing the rib dose. The indications
for SBRT at Kyushu University have been described in detail by Asai
et al. [12]. Table 1 summarizes more information about the patients,
and Table 2 shows details of the fractured ribs. We defined overlap-
ping rib–PTV distance as the overlapped maximum distance between
the lateral border of the PTV and the rib surface on three orthogonal
planes. The median overlapping rib–PTV distance was 0.4 cm. The
maximum number of RIRFs was three in one patient. We selected
patients who developed RIRF after SBRT with 3D-CRT as being
good candidates in which to reduce radiation doses to the chest wall.
The Ethics Committee at Kyushu University approved the study.
Target and risk organs delineation
The gross tumor volume (GTV) was contoured on each axial CT
slice using a pulmonary window setting. The clinical target volume
(CTV) was equivalent to the GTV. The internal target volume
(ITV) was defined based on 3D tumor motion using fluoroscopy.
The PTV was created from the ITV by adding a uniform margin of
5 mm in all directions. All ribs were contoured just on the rim
(except for cartilage) under the bone window setting. The chest
wall was contoured essentially as described in Refs. [15] and [17]
Table 1. Patient characteristics
Characteristic No. (median)








Tumor size [cm] 1.2–3.8 (2.4)
PTV volume [cm3] 10.28–59.87 (36.51)
Table 2. Details of the fractured ribs
Characteristics No. (median)
Number of fractured ribs 28
Location of fractured ribs
Right 12
Costae verae (rt1/rt2/rt3/rt4/rt5/rt6/rt7) 12 (–/1/3/3/2/1/2)
Costae spuriae (rt8/rt9/rt10/rt11/rt12)
Left 16
Costae verae (lt1/lt2/lt3/lt4/lt5/lt6/lt7) 13 (–/–/3/3/3/2/2)
Costae spuriae (lt8/lt9/lt10/lt11/lt12) 3 (2/1/–/–/–)
Overlapping rib–PTV distance [cm] 0.2–0.6 (0.4)
ltx = developed RIRF with X-place in left ribs, rtx = developed RIRF with X-place in
right ribs.
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by uniformly expanding the lung by 2 cm, including the exit site of
the spinal nerve root and part of the sternum, and excluding the
spinal cord and soft tissue in mediastinum in terms of the ipsilateral
lung (Fig. 1).
Treatment planning
All patients were retrospectively re-planned for 3D-CRT in accord-
ance with the JCOG0702 protocol [18], and VMAT plans were
newly created to be compared with the 3D-CRT plans. The pre-
scription of original 3D-CRT plans was defined at the isocenter,
and the plans were calculated with a pencil beam convolution
(PBC) algorithm. The prescription of the original plans was chan-
ged from the point prescription to the volume prescription to equal-
ize the target dose distribution of 3D-CRT and VMAT plans.
Additionally, Acuros XB (AXB) was adopted instead of the PBC
algorithm because it is known to have high accuracy for the dose
calculation in lung SBRT plans with small PTVs compared with
PBC algorithms [19]. The treatment planning system (TPS) was
Eclipse, ver. 11 (Varian Medical Systems, Palo Alto, CA, USA), and
the treatment beam was 6-MV or 10-MV photon beams using a
TrueBeam STx linear accelerator (Varian Medical Systems). The
prescribed dose was 48 Gy in four fractions, and the planning objec-
tives aimed to cover the PTV with 95% of the prescribed dose
(D95% to 48 Gy) in both plans. The homogeneity index (HI) was
defined as a ratio of the maximum dose to the minimum dose in
the PTV. An HI of <1.6 was adopted in this study [18]. The dose
calculation was performed with a calculation grid resolution of
2.5 mm, and a heterogeneity correction was used in all the plans.
A radiation oncologist at Kyushu University slightly modified some
field arrangements (within ± 10°) in all 3D-CRT plans in order to
avoid a deformation of the dose distribution due to the change in cal-
culation algorithm and prescription, while generally keeping the field
arrangements of the original plan and considering target conformity.
The field arrangement for the 3D-CRT plan was 7 or 8 using a non-
coplanar technique. A margin of 5 mm was applied from the PTV to
the multileaf collimator (MLC) leaves for all fields.
The field arrangement for the VMAT plan included two partial
arcs of 200° (e.g. 339° to 179° for left lung, and 21° to 181° for
right lung) with a coplanar technique in terms of the ipsilateral lung
to maximally reduce doses to the contralateral lung. All plans used
30° collimator rotation for two different arcs. The dose constraints
for all lungs were V20 ≤ 5% (<5% of the volume receiving 20 Gy),
V10 ≤ 10%, V5 ≤ 15% and Dmean ≤ 4 Gy, and the doses for the frac-
tured ribs and chest wall were maximally reduced. The irradiated
dose to the intact ribs was also maximally reduced.
Dosimetric parameters
The D98% (dose received by ≥98% of the PTV volume) and con-
formation number (CN) of the PTV were calculated. Riet et al.








where Vt100 is the target volume receiving at least the prescribed
dose, Vtvol is the target volume, and V100 is the total volume receiv-
ing at least the prescribed dose [20]. A value close to unity means
identical target coverage.
The D2cm3 (dose received by 2 cm
3 of the objective structure),
the V40 and V30 of the fractured ribs, the V30 of the chest wall, and
the Dmean, V20 and V5 of the lungs were also calculated.
Statistical analysis
Data were statistically analyzed using JMP Pro 11 software (SAS
Institute, Inc., Cary, NC, USA). All P values were two-sided, with a
level of significance set at 5%. The dosimetric parameters of the
PTV and OARs were compared between the 3D-CRT and VMAT
plans using the Wilcoxon signed rank test.
RESULTS
A summary of the dosimetric parameters is shown in Table 3.
Regarding the target, D98% did not significantly differ between the
two plans, whereas CN was significantly improved in the VMAT
plans (P < 0.0001). Regarding the OARs, all dosimetric parameters
of the fractured ribs were significantly decreased in the VMAT,
compared with in the 3D-CRT plans (P < 0.0001). The V30 of the
chest wall and all dosimetric parameters of the lung were signifi-
cantly decreased in the VMAT plans (P < 0.0001 for both, except
for V5 of lung, P = 0.0002). Especially, irradiated volumes of frac-
tured ribs were remarkably decreased in the VMAT plans, and the
reduction rate of the V40 and V30 for fractured ribs were −52.4%
and −41.5%, respectively. Figure 2 shows the dose distribution and
dose–volume histogram (DVH) for one patient in whom the CN
value improved in the VMAT, compared with in the 3D-CRT plan
(0.79 vs 0.57). The dose distribution was more conformable using
the VMAT, than the 3D-CRT plan. The irradiated volume to the
fractured ribs (lt3, lt4) and the chest wall was decreased in the
VMAT plan. The irradiated lung volume also decreased, whereas
the lung volume receiving <2 Gy increased in the VMAT plan.
These results revealed that the irradiated volume of the OARs adja-
cent to the target was reduced by the VMAT, compared with the
Fig. 1. The outline indicates how to contour the chest wall.
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3D-CRT plans, although the low-dose irradiated lung volume
increased.
DISCUSSION
This study investigated that whether or not the dose to the chest
wall could be decreased by VMAT in patients with RIRFs and com-
pared the dose to the target and the OARs adjacent to the target
between the two plans. The present results indicate that VMAT
reduced the dose to the chest wall, ribs and lung, while offering
more conformable dose distribution for the target compared with
3D-CRT in SBRT for a peripheral lung tumor adjacent to the chest
wall.
In lung cancer patients, Ding et al. compared the dosimetric para-
meters of OARs adjacent to the chest wall (average 2 cm) between a
static field plan and VMAT, and reported that VMAT significantly
reduced the dose to chest wall and ribs, and the average improvement
rates of the V30 were 74.3% and 60.8%, respectively [16]. However,
these findings did not take differences in the target dose into account
between the two plans. Indeed, a highly conformal dose distribution for
the target with a steep dose gradient neighboring some healthy tissues
causes underdosing of the target in VMAT plans. The present study
compared the target and OARs doses between VMAT and 3D-CRT
plans in RIRF patients (overlapping rib–PTV distance >0.2 cm). The
VMAT plans achieved better OARs sparing without compromising tar-
get dose coverage. The median reduction rates of the V30 of the chest
wall and fractured ribs were 34.4% and 41.5%, respectively (Table 3). It
is suggested that VMAT could decrease the dose to the OARs adjacent
to the target, such as chest wall and ribs, without underdosing of the
target, even when the target is partially overlapping with these OARs.
Ding et al. also reported that one patient observed an increase in the
V20 of the ipsilateral lung with the VMAT plan. However, this tendency
Table 3. Summary of dosimetric parameters
Objects Criteria 3D-CRT VMAT aRatio [%] P value
PTV D98% [Gy] 47.00 (46.88–47.13) 46.85 (46.56–47.08) −0.3 0.07
CN 0.58 (0.53–0.62) 0.83 (0.79–0.87) 43.1 <0.0001
Rib D2 cm3 [Gy] 40.46 (31.36–47.97) 26.95 (21.44–36.67) −33.4 <0.0001
V40 [cm
3] 2.12 (1.05–2.93) 1.01 (0.08–1.70) −52.4 <0.0001
V30 [cm
3] 2.87 (2.20–4.25) 1.68 (0.78–2.91) −41.5 <0.0001
Chest wall V30 [cm
3] 29.97 (22.20–52.35) 19.65 (10.17–33.69) −34.4 <0.0001
Lung Dmean [Gy] 4.80 (3.28–6.18) 4.13 (2.83–5.26) −14.0 <0.0001
V20 [%] 6.63 (3.82–9.29) 5.46 (3.13–8.20) −17.7 <0.0001
V5 [%] 21.33 (16.36–28.88) 18.18 (12.87–21.26) −14.8 0.0002
Value = median (interquartile range), D98% = dose received by at least 98% of volume of the PTV, CN = conformation number, D2cm3 = dose received by volume of
2 cm3 of the fractured rib, Vx = volume received by at least x Gy of the dose,
aRatio [%] = ratio of the median value between VMAT and 3D-CRT (VMAT/3D-CRT).
Fig. 2. The dose distributions and dose–volume histograms (DVHs) of normal tissues showing 3D-CRT and VMAT plans for
one patient with primary cancer in left lung. Dose distribution with 3D-CRT plan (left); dose distribution with VMAT plan
(right). Values of CN in 3D-CRT and VMAT plans were 0.57 and 0.79, respectively.
ltx = developed RIRF with X-place in left ribs.
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was not shown in this study. We considered that this was due to differ-
ences in the dose constraints and the evaluated volume of the lung. We
noted that the low-dose irradiated lung volume (i.e. volume of lung irra-
diated with <5 Gy) might increase, since the V5 increased by 2.3% in
one of 16 patients (2.3%) in this study.
Some investigators have described risk factors of RIRF and chest
wall pain. Asai et al. analyzed the risk factors for RIRF using receiver
operating characteristics (ROC) curves and found a close correlation
between Dmax, V40 and V30 for the ribs and RIRFs after SBRT [12].
They estimated the risk of RIRFs in 3 years was 51.6% when the V40
of the ribs above 0.29 cm3, whereas 2.01% when the V40 was less
0.29 cm3. Regarding the V30 of the ribs, estimated the risk was 45.8%
when the V30 was above 1.35 cm
3, while 2.2% when the V30 was less
1.35 cm3. Comparison of our results with these cut-off values, V40 ≤
0.29 cm3 occurred in 1 of a total of 28 ribs (3.6%) with 3D-CRT plans
and in 10 ribs (35.7%) with VMAT plans, and V30 ≤ 1.35 cm3
occurred in 4 ribs (14.3%) with 3D-CRT plans and in 10 ribs (35.7%)
with VMAT plans, respectively. Eight ribs met the both cut-off values
(i.e. V40 ≤ 0.29 cm3 and V30 ≤ 1.35 cm3) in “VMAT” plans. It is sug-
gested that 8 of total the 28 ribs (28.6%) could be have a decreased
risk of RIRF (down to 2%) by using VMAT instead of 3D-CRT in
SBRT. Welsh et al. assessed the correlations between the chest wall
dose and adverse events, and found that the V30 for the chest
wall closely correlates with the incidence of skin toxicity and
chest wall pain after SBRT [7]. They estimated that the risk of
skin reaction rate was 44% and 22% when V30 of the chest wall
was above or less than 50 ml, respectively. The risk of chest wall
pain was estimated at 18% and 2.7% when the V30 was above or
less than 30ml, respectively. When comparing our results with these
values, the V30 of the chest wall ≤ 50ml was 12 of 16 patients (75%)
with 3D-CRT plans, whereas 16 patients (100%) with VMAT plans
showed the V30 ≤ 50ml in terms of estimated the risk of skin toxicity.
About the risk of chest wall pain, the V30 of the chest wall ≤ 30ml
was 8 of 16 patients (50%) with 3D-CRT plans, while 10 of 16
patients (62.5%) with VMAT plans showed V30 ≤ 30ml. It is sug-
gested that VMAT plans could reduce the dose to the ribs and chest
wall compared with 3D-CRT plans, and that this might help decrease
the risk of adverse events such as RIRF and chest wall pain.
Some studies reported that a short distance from the rib and
chest wall to the tumor (<1.0–2.0 cm) increases the of risk of
RIRFs [12–14]. However, in the evaluation of risk of RIRF, the use
of rib–tumor distance as a risk factor is not appropriate because the
dose to the ribs and chest wall can be decreased by use of intensity-
modulated radiation therapy (IMRT) techniques, including VMAT.
In our results, we found that VMAT reduced these OARs doses;
the median reduction rates of V40 and V30 for fractured ribs and
V30 for chest wall were −52.4%, −41.5% and −34.4%, respectively.
Therefore, when IMRT techniques, including VMAT, are used to
treat a peripheral lung tumor adjacent to the chest wall, evaluation
of rib–tumor distance as a risk factor may not be appropriate.
One concern about lung SBRT using VMAT is the interplay
effect. The interplay effect causes overdosage and underdosage
within the target due to interplay between respiration-induced
tumor motion and MLC motion, and single-arc and single-fraction
treatment correlated with noticeable dose deviations [21, 22].
According to these findings, lung SBRT with VMAT might cause
dose deviations in the target due to the interplay effect, because this
treatment is generally completed in a few fractions with 1 or 2 arcs
per fraction. Ong et al. compared convolved static dose measure-
ments, including 10 different respiratory phases, with dynamic dose
measurement in VMAT plans by gamma analysis with evaluation
criteria of 3% dose difference and 1 mm distance-to-agreement
(DD/DTA: 3%/1 mm), and reported that the average surface with
gamma >1 was 1.3% in 1 arc, and further decreased to 0.3% in
2 arcs [22]. The dose deviations in the center of the PTV averaged
1–2%. Therefore, it is suggested that the dosimetric effects of inter-
play might be negligible in lung SBRT with VMAT, especially the
one consists of 2 arcs.
Our study has several limitations. We did not include patients with
an overlapping rib–PTV distance of >0.6 cm. However, our selected
cases included patients in whom RIRFs occurred at various locations in
lung (Table 2). Our results offer a benchmark for considering the risk of
RIRF and chest wall pain in clinical practice. Finally, we did not apply
clinical approaches, such as adjustments to the MLC position on the
side of the chest wall, in the re-planned 3D-CRT. The 3D-CRT plans
were created based on the JCOG0702 protocol [18], that is, 5 mm of
MLC margin was adopted in the plans. The authors would like to note
that the results of this study should not be interpreted as saying that a
VMAT plan is generally superior to a 3D-CRT plan, because 3D-CRT
still retains the capacity for reduced OAR doses by adjusting an edge of
the MLC in a more sophisticated way than is described by the
JCOG0702 protocol. If the MLC margin was to be diminished (that is,
from 5 to 0 mm) on the side of the chest wall, the dose to the chest
wall could be reduced. However, VMAT can reduce the dose to the
chest wall and ribs, even when the target is partially overlapping with
these OARs. We aim to clarify the relationships between chest wall dose
and occurrence of RIRF in lung SBRT with VMAT in the future.
In conclusion, the VMAT plan allowed a reduction in the radi-
ation dose to the chest wall, ribs and lung, while improving target
conformity compared with 3D-CRT for SBRT used to treat periph-
eral lung tumors. Reducing the dose to the OARs helps to decrease
the risk of some adverse events, such as RIRF and chest wall pain,
after SBRT.
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